StonvexLoading…
StonvexStonvexStonvexCore line items from TLN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.57B | $2.52B | $1.76B | $1.06B |
Operating Income | $210.00M | $-90.00M | $223.00M | $-40.00M |
Net Income | $63.00M | $-219.00M | $144.00M | $-63.00M |
EPS (Diluted) | $1.33 | $-4.79 | $2.96 | $-1.38 |
Total Assets | $10.99B | $10.90B | $6.10B | $5.83B |
Total Liabilities | $9.92B | $9.81B | $4.63B | $4.58B |
Cash & Equivalents | $1.02B | $689.00M | $497.00M | $122.00M |
Free Cash Flow OCF − CapEx | $419.00M | $606.00M | $352.00M | $-116.00M |
Shares Outstanding | 45.40M | 45.69M | 45.69M | 45.66M |